Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   PCE(x) 31.1128.35-21.6327.368.43

What is the latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS is 31.11 based on Mar2026 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202631.11
Mar202528.35
Mar2024-21.63
Mar202327.36
Mar20228.43

How is Price to Cash Earnings (PCE) of GLENMARK PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2026 31.11
9.74
Mar2025 28.35
Positive
Mar2024 -21.63
Negative
Mar2023 27.36
224.56
Mar2022 8.43 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹65,611.5 Cr -1.7% 0.6% 12.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr -2.3% -3.3% 15.7% Stock Analytics
DIVIS LABORATORIES ₹227,958.0 Cr 0.3% 16.3% 44.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,990.0 Cr 2.8% -0.5% 37.1% Stock Analytics
CIPLA ₹116,141.0 Cr -3.1% -1.2% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,604.4 Cr -2.9% -3% -3.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.7%

0.6%

12.2%

SENSEX

-0.7%

0.1%

-3.4%


You may also like the below Video Courses